How many employees does Arcus Biosciences, Inc. have?

Arcus Biosciences, Inc. reported 601 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is down 4.1% from a year earlier.

What is Arcus Biosciences, Inc.'s revenue per employee?

Arcus Biosciences, Inc. brought in $247M of revenue in fiscal Dec 2025, which is $411K per employee. That ranks 24 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Arcus Biosciences, Inc. employees and revenue per employee

RCUS · Biotechnology · $3.49B market cap

Arcus Biosciences, Inc. had 601 employees at the end of fiscal Dec 2025, down 4.1% from a year earlier. Revenue for the year was $247M, down 4.3% from a year earlier, or $411K per employee. Revenue fell, and headcount fell or held flat with it.

Employees

601

-4.1% YoY

Revenue

$247M

-4.3% YoY

Revenue / employee

$411K

Peer median $602K

Rank in industry

24 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2018

Hover a year for the numbers.

RCUS employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	601	$247M	$411K	-4.1%	-4.3%
Dec 2024	627	$258M	$411K	+8.7%	+120.5%
Dec 2023	577	$117M	$203K	+15.4%	+4.5%
Dec 2022	500	$112M	$224K	+36.6%	-70.8%
Dec 2021	366	$383M	$1.05M	+55.1%	+391.0%
Dec 2020	236	$78.0M	$331K	+69.8%	+420.0%
Dec 2019	139	$15.0M	$108K	+28.7%	+79.6%
Dec 2018	108	$8.4M	$77K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Arcus Biosciences, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
TGTX TG Therapeutics, Inc.	399	$616M	$1.54M	Efficient growth
KRYS Krystal Biotech, Inc.	295	$389M	$1.32M	Efficient growth
ADMA ADMA Biologics, Inc.	647	$510M	$789K	Leaner
BBIO BridgeBio Pharma, Inc.	834	$502M	$602K	Efficient growth
ADPT Adaptive Biotechnologies Corporation	624	$277M	$444K	Efficient growth
RCUS Arcus Biosciences, Inc.	601	$247M	$411K	Contracting
TWST Twist Bioscience Corporation	979	$377M	$385K	Efficient growth
INSM Insmed Incorporated	1,664	$606M	$364K	Efficient growth
IBRX ImmunityBio, Inc.	691	$113M	$164K	Efficient growth

Every Healthcare company

Questions about Arcus Biosciences, Inc.

How many employees does Arcus Biosciences, Inc. have?: Arcus Biosciences, Inc. reported 601 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 25, 2026. That is down 4.1% from a year earlier.
What is Arcus Biosciences, Inc.'s revenue per employee?: Arcus Biosciences, Inc. brought in $247M of revenue in fiscal Dec 2025, which is $411K per employee. That ranks 24 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare RCUS with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Arcus Biosciences, Inc.'s annual reports (Form 10-K), latest filed February 25, 2026. This is data, not a recommendation to buy or sell RCUS.